Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-23T21:31:54.431Z Has data issue: false hasContentIssue false
  • English
  • Français

High-dose antipsychotic medication

Published online by Cambridge University Press:  02 January 2018

David Abrahamson
David Abrahamson*
Affiliation:
Goodmayes Hospital, Essex IG3 8XJ
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 165 , Issue 2 , August 1994 , pp. 269
Copyright
Copyright © Royal College of Psychiatrists, 1994 

References

Cookson, I. (1987) The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime. International Clinical Psychopharmacology, 2, 141–149.CrossRefGoogle ScholarPubMed
Drury, V. (1992) Monitoring recovery from acute psychosis. In Innovations in the Psychological Management of Schizophrenia (eds Birchwood, M. & Tarrier, N.). Chichester: Wiley.Google Scholar
Sramek, J. J., Gaurano, V., Herrera, J. M., et al (1990) Patterns of neuroleptic usage in continuously hospitalised chronic schizophrenic patients: evidence for development of drug tolerance. DICP, The Annals of Pharmacotherapy, 24, 7–10.Google ScholarPubMed
Weiden, P., Schooler, N. R., Severe, J. B., et al (1993) Stabilisation and depot neuroleptic doses. Psychopharmacology Bulletin, 29, 269–275.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.